FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants

Estimated reading time: 1 minutes

• About The Author

FDA approved and authorized for emergency use updated mRNA COVID-19 vaccines (2024-2025 formula) to more closely target currently circulating variants to prevent COVID-19 and to provide better protection against serious consequences of COVID-19.

About The Author

See author's posts

Trending

Google Ranking Factors and Marketing KPIs